RNS Number : 8447H
Tristel PLC
18 November 2025
 

TRISTEL plc

("Tristel" or the "Company")

 

Notice of AGM and Posting of Annual Report and Accounts

 

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that the Notice of Annual General Meeting ("AGM") and the 2025 Annual Report and Accounts for the year ended 30 June 2025 have been posted to shareholders yesterday and is available to download from the investor section of Company's website - https://investors.tristel.com/financial/

 

The Company's AGM will be held on Thursday 11 December 2025 at 11.00am at the Company's headquarters, Unit 1b Lynx Business Park, Fordham Road Snailwell, Newmarket, Cambridgeshire, CB8 7NY.

 

 

For further information please contact:

Tristel plc

Via Walbrook PR

Matt Sassone, Chief Executive Officer

www.investors.tristel.com

Anna Wasyl, Chief Financial Officer




Walbrook PR Ltd

Tel: 020 7933 8780 or [email protected]

Paul McManus / Lianne Applegarth / Anna Dunphy 

Mob: 07980 541 893/ 07584 391 303/ 07876 741 001  



Cavendish Capital Markets Ltd

Tel: 020 7220 0500

Geoff Nash / Callum Davidson/Trisyia Jamaludin (Corporate Finance)


Sunila de Silva (Corporate Broking) / Louise Talbot (Sales)


 

A blue and purple sign with white text AI-generated content may be incorrect.

 

About Tristel plc

Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, a more sustainable alternative to commonly used pre-wetted plastic wipes.

 

Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 270 people across 16 subsidiaries selling into 40+ countries. The Company targets double digit revenue growth annually and an EBITDA margin of at least 25% and the business is profitable, with no debt and has a progressive dividend policy.

 

The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL).

 

For more information about Tristel's product range please visit: https://tristel.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAUBUORVOUAAAA